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Abstract
Sporadic canine colorectal cancers (CRCs) should make excellent models for studying the corresponding human cancers. To
molecularly characterize canine CRC, we investigated exonic sequence mutations of adenomatous polyposis coli (APC), the
best known tumor suppressor gene of human CRC, in 23 sporadic canine colorectal tumors, including 8 adenomas and 15
adenocarcinomas, via exon-resequencing analysis. As a comparison, we also performed the same sequencing analysis on 10
other genes, either located at human 5q22 (the same locus as APC) or 18q21 (also frequently altered in human CRC), or
known to play a role in human carcinogenesis. We noted that APC was the most significantly mutated gene in both canine
adenomas and adenocarcinomas among the 11 genes examined. Significantly, we detected large deletions of $10 bases,
many clustered near the mutation cluster region, as well as single or two base deletions in ,70% canine tumors of both
subtypes. These observations indicate that like in the human, APC is also frequently altered in sporadic colorectal tumors in
the dog and its alteration is an early event in canine colorectal tumorigenesis. Our study provides further evidence
demonstrating the molecular similarity in pathogenesis between sporadic human and canine CRCs. This work, along with
our previous copy number abnormality study, supports that sporadic canine CRCs are valid models of human CRCs at the
molecular level.
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Introduction
Sporadic canine cancers should make excellent models for
studying the corresponding human cancers for a number of
reasons. First, companion animals such as the dog share the same
environment as the human, and hence are exposed to the same
carcinogens. Indeed, risk factors for cancer development in dogs
include air pollutants and other environmental toxins, diet and
obesity, advancing age, and other similar factors [1]. Second, these
cancers are naturally occurring and heterogeneous, and hence
capture the essence of sporadic human cancers, unlike most
genetically modified or xenograft rodent cancer models [2]. In
fact, numerous anatomic and clinical similarities have been
reported for the same type of cancers between the human and
the dog [3–9]. Additionally, the dog genome has been sequenced
to 7.6-fold coverage and a relatively accurate version of its
sequence assemblies is available [1], which is unlike another
companion animal, the cat, whose genome has only been
sequenced to 2.8-fold coverage [10,11]. This makes many
experimental and bioinformatics analyses possible with the dog,
but impossible with the cat. Importantly, the dog genome is
rearranged when compared to the human genome [1,12].
Because of these advantages, many researchers, including the
Canine Comparative Oncology and Genomics Consortium (www.
ccogc.net) and us (i.e., we are trying to develop a dog-human
comparison strategy for cancer driver-passenger distinction [12–
15]), have been actively promoting the immense value of sporadic
canine cancers in basic and clinical research [e.g., see references
3–9,15]. However, the contribution of sporadic canine cancers
towards understanding and treating human cancers clearly hinges
upon the degree of molecular homology between canine cancers
and their human counterparts. Unfortunately, despite of numer-
ous anatomic and clinical similarities being reported [3–9], in
contrast to their human counterparts, pathogenesis mechanisms of
sporadic canine cancers remain poorly understood at the
molecular level. Hence, molecular characterization of sporadic
canine cancers becomes essential and urgent. Towards this goal,
we conducted the study reported below.
Human colorectal cancer (CRC) is one of the best-understood
systems for studying the molecular mechanisms of cancer initiation
and progression [16–33]. The tumorigenesis model proposed by
Vogelstein and colleagues [17] includes alteration of individual
genes such as APC, as well as development of genomic instability in
the form of either chromosome instability (CIN) or microsatellite
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e50813instability (MSI) [16–21,24–27]. We have recently demonstrated
that CIN and MSI occur in sporadic canine colorectal tumors in
the same fashion as their human counterparts [15]. Regarding the
APC gene, a previous study reported a marked decrease of the APC
protein expression in canine malignant colorectal tumors via
immunohistochemical staining [34] (another related study also
reported the altered cellular location of the b-catenin protein in
canine colorectal tumors [35], a likely result of a defective APC).
Other than these, to the best of our knowledge, we have not
identified a single publication that investigated genomic sequence
mutation of APC in sporadic canine colorectal tumors. This
drastically differs from the human, where numerous sequencing
studies have been published [e.g., see references 16–19, 29–32]. In
fact, databases documenting APC mutations have been established
(e.g., www.umd.be/APC/) [32].
To better understand APC abnormalities in dogs, we investi-
gated its exonic sequence mutations in 23 sporadic canine
colorectal tumors (8 adenomas and 15 adenocarcinomas) via
exon-resequencing. For comparison purposes, we also performed
the same sequencing analysis with 10 other genes, either located at
human 5q22 (the same locus as APC) or 18q21 (also frequently
altered in human CRC [16–33]), or known to play a role in
human carcinogenesis (see the Results section). The study revealed
that APC, the best-known tumor suppressor of human CRC, was
the most recurrently deleted gene in both canine adenomas and
adenocarcinomas. The study provides further evidence demon-
strating the molecular similarity in colorectal tumorigenesis
between humans and dogs. This, along with our previous CIN/
MIN study [15], supports that sporadic canine CRCs are valid
models of human CRCs at the molecular level.
Methods
Canine colorectal tissue samples
Over 23 formalin-fixed, paraffin-embedded (FFPE) canine
adenomas and adenocarcinomas were provided by the William
R. Pritchard Veterinary Medical Teaching Hospital of the
University of California-Davis School of Veterinary Medicine
(UCDSVM). In addition, fresh-frozen samples of canine colorectal
tumors and normal tissues, acquired during surgery, were obtained
from the same hospital of the UCDSVM, the Veterinary Teaching
Hospital of the University of Georgia Athens College of Veterinary
Medicine (UGACVM), as well as the Animal Cancer Tissue
Repository at the Colorado State University (CSU). After washing
in phosphate-buffered saline, the samples were snap-frozen in
liquid nitrogen for 10 minutes and then stored at 280uC until
further analyses.
Dog tumor and normal samples obtained from the CSU were
collected with owner informed consent and the CSU’s Institutional
Animal Care and Use Committee (IACUC) approval # 2963.
Only tumors samples (no normal samples) were obtained from the
UGACVM and the UCDSVM. These tumor samples were from
dogs that had the naturally-occurring disease, and were acquired
after tumor excision or biopsy that was necessary for treatment of
the animals. No treatments were altered for the purpose of this
study. Being that tumor samples were acquired after tumor
excision or biopsy for the purpose of treating the dogs, approval
from the IACUC of the respective university (UGA or UCD) was
not required.
DNA extraction
Fresh-frozen sample cryosectioning, H&E staining, and cryo-
microdissection were performed as described previously [15] to
enrich tumor cells for the tumor samples and normal colon
epithelial cells for the normal samples. Then, genomic DNA was
extracted from the dissected tissues using the DNeasy Blood &
Tissue Kit (cat. no. 69506) from QIAGEN. Genomic DNA
extraction from FFPE samples was performed using the QIAGEN
QIAamp DNA FFPE Tissue Kit (cat. no. 56404), following the
manufacturer’s instruction.
Bi-directional exon-resequencing and mutation detection
Primer design and PCR amplification of exons of the chosen
genes, as well as bi-directional sequencing of the PCR products
were performed at The J. Craig Venter Institute in Maryland as
previously described [23]. Base-calling using the software Phred
(www.phrap.org/phredphrapconsed.html), sequence trimming
with the software Lucy (www.tigr.org/software/sequencing.
shtml), exon sequence assembly, as well as comparison with the
published dog reference genome [1] for mutation detection were
performed as described [23]. A cutoff Phred quality score of 20
was used to reduce false positives due to sequencing errors,
ensuring that only high quality bases with an error rate of #1%
were eligible for mutation findings.
Results
Exon-resequencing of APC and other genes in sporadic
canine colorectal tumors
In humans, colorectal tumorigenesis is proposed to be initiated
by inactivation of the APC gene, as its alteration is the earliest
event yet identified in sporadic colorectal tumorigenesis and
.85% of sporadic human colorectal tumors carry somatic
mutations of APC [16–19,29–32]. To investigate if these are also
true in dogs, we investigated APC in 23 sporadic canine colorectal
tumors, including 8 adenomas and 15 adenocarcinomas (Table
S1), of FFPE tissue samples archived at the William R. Pritchard
Veterinary Medical Teaching Hospital of the UCDSVM. As
illustrated by Fig. 1, in adenomas, the basement membrane is
preserved and epithelial cells proliferate only in mucosa; in
invasive adenocarcinomas, however, the basement membrane is
disrupted and proliferating epithelial cells spread into submucosa.
Hence, similar tumor initiation and progression histological
changes were observed in canine tumors as in their human
counterparts.
We performed bi-directional exon-resequencing as previously
described [23] to investigate sequence mutations in APC exons in
these sporadic canine colorectal tumors. Specifically, we se-
quenced 14 of the 15 coding exons (as we could not design
efficient primers to amplify exon 4) with 8,454 bases total for the
canine APC gene, and were able to assemble the entire exon
sequences from the forward and reverse sequences of the mostly
overlapping PCR products in many cases, as described previously
[23]. Combined all 23 tumors, we generated 772,729 base
sequences, yielding coding exon assemblies of 140,631 bases
(44,715 bases for adenomas and 95,916 bases for adenocarcino-
mas) in total for the canine APC gene (Table 1).
For comparison purposes, we also performed the same
sequencing analysis on 119 exons totaling to 17,709 bases from
10 other canine genes. Seven such genes were chosen because they
are located at human 5q22 (DP1 and MCC), the same locus as
APC, or 18q21 (SMAD4, SMAD2, SMAD7, MBD1 and MBD2) also
recurrently altered in human CRC [16–33]. The remaining three
genes, located outside these two regions, were included because of
their roles in human carcinogenesis reported in literature. These
include BIN1 (a MYC-interacting tumor suppressor gene [36]) and
ERCC3 (functioning in DNA excision repair [37]) at human
2q14.3, as well as CTNNA1 (a-catenin, also involved in intestinal
APC Altered in Sporadic Canine Colorectal Tumors
PLOS ONE | www.plosone.org 2 December 2012 | Volume 7 | Issue 12 | e50813Figure 1. Major histopathological subtypes of canine colorectal
tumors investigated. Shown from top to bottom are H&E staining
images for normal colon (mucosa, submucosa, and muscle layers as
indicated), colorectal adenoma, and colorectal adenocarcinoma. In the
adenoma (middle), there is preservation of a distinct basement
membrane (arrows). In the adenocarcinoma (bottom), a section of the
basement membrane (small arrows) has been disrupted and penetrated
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PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e50813tumorigenesis [38]) at human 5q31.2. Combining all tumors
together, we produced 2.7 Mb sequences, yielding coding exon
assemblies of 269,163 bases (93,000 bases for adenomas and
176,163 bases for adenocarcinomas) in total for the 10 canine
genes (Table 1).
We then aligned the assembled sequences to the corresponding
exon reference sequence from the published dog genome [1] for
mutation finding. To reduce false results that could be introduced
by sequencing problems, bases with Phred quality scores of below
20 were excluded to ensure that only high quality bases with an
error rate of #1% were eligible for mutation findings. We also
exclude those changes already reported by the single nucleotide
polymorphism (SNP) database (www.ncbi.nlm.nih.gov/projects/
SNP/), which are mostly variations among normal dog individuals
[1,39]. Below we will describe sequence aberrations found in the
canine APC exons and their comparison to those of the other 10
canine genes described above.
Large deletions frequent in canine APC exons and
clustered near the human mutation cluster region (MCR)
and at the C-terminal end
Because the UCDSVM did not archive the matching normal
tissue samples for these tumors, we could not perform the same
sequencing analysis with the matched normal DNA. Hence, it was
difficult to distinguish sequence variations existing among normal
individual dogs (i.e., germline mutations), which are mostly SNPs
[1,39], from cancer-related somatic mutations. This is especially so
considering that only about 3.3 million SNPs are currently
released for the dog, compared to over 187 million for the human
(www.ncbi.nlm.nih.gov/projects/SNP/). Consequently, we first
focused on large scale changes, which often disrupt a segment of
the protein and should be less frequent in coding regions among
normal dogs, even for those from different breeds [40,41] (and
thus have a higher probability to be cancer-related somatic
changes), compared with base substitutions [1,39] (which could
cause no changes in protein sequences - synonymous mutations,
change one amino acid to another – missense mutations, or less
frequently result in a premature stop codon - nonsense mutations).
Consistent with our canine array comparative genome hybrid-
ization studies [15], large deletions of $10-bases long were
frequent in canine APC exons, disrupting a total of 2,134 bases in 5
(63%) adenomas and 5,024 bases in 11 (73%) adenocarcinomas
(Table 1). As a result, as many as 2,434 codons, 736 for adenomas
and 1,698 for adenocarcinomas, were disrupted (Table 2). Except
for one adenocarcinoma that carried a 57 base-deletion between
the oligomerisation domain and the armadillo region, all other
deletions were found downstream of the armadillo region (Fig. 2).
Interestingly, these large deletions clustered in several regions of
APC (Fig. 2). The first one, detected in the 10 tumors (3 adenomas
and 7 adenocarcinomas), was within codons 1143–1250, spanning
the 15amino acid (aa) repeats region and downstream (Fig. 2). It is
also near the beginning of mutation cluster region (MCR),
spanning codons 1286–1513, of the human APC gene [30,31].
The other two clusters were found near the C-terminal end after
the basic domain, one within codons 2464–2490 (found in 5
adenomas and 11 adenocarcinomas) and another within the EBI
binding domain between codons 2616 to 2734 (found in 4
adenomas and 10 adenocarcinomas) (Fig. 2).
Large deletions were much less frequent in the other 10
genes sequenced. Unlike APC exons described above, large
deletions were significantly less frequent in the other 10 genes.
Specifically, only 229 bases in total were deleted for adenomas,
disrupting 83 codons for 3 genes in 5 adenomas. For adenocar-
cinomas, 377 bases total were deleted, disrupting 124 codons for 4
genes in 11 adenocarcinomas (Tables 1 and 2). Hence, the large
deletion rate is .18 times lower for adenomas and 25 times lower
for adenocarcinomas for these genes, compared to APC (Tables 1
and 2).
Because the same samples were sequenced for all the genes, the
rare occurrence of large deletions in the 10 non-APC genes, as
described above, indicate the unlikelihood that the frequent large
deletions in APC could be artifacts arisen from sequencing FFPE
samples. Furthermore, by studying the corresponding sequences
from the published dog genome [1], we observed neither repetitive
sequences nor abnormal GC contents (44%, 51%, and 48%,
within the normal range of exonic sequences) for the three most
frequently deleted regions in APC shown in Fig. 2. Thus, based on
their sequence contents, these regions are not prone to sequencing
failure. Lastly, we performed real time quantitative PCR (qPCR)
to amplify these regions with 15 fresh-frozen colorectal tumor or
normal tissue samples listed in Table S2. The analysis confirmed
that these regions were indeed significantly deleted in the tumors
(p,0.05). In summary, these studies indicate that the frequently
detected large deletions in APC exons are unlikely artifacts of our
sequencing analysis, but are most likely cancer-related somatic
changes instead.
Small deletions frequent in canine APC exons and with a
substantial portion found in the armadillo region
We also investigated small indels, which often result in frame-
shift mutations disrupting protein function. We observed that 155
codons of diverse exons, including 60 codons from 8 adenomas
(100%) and 95 codons from 14 adenocarcinomas (93%), were
disrupted by small indels (i.e., single base or two base insertions/
deletions) (Tables 1 and 2). In addition, clustering within the
armadillo domain (codons 453–767) and around the 15 aa repeats
region (codons 1020–1169), nearly one third of these indels were
found at the N-terminal portion of the APC protein, disrupting 22
codons in 7 adenomas and 25 codons in 10 adenocarcinomas
(Fig. 2). In comparison, a total of 255 codons (84 from 8 genes in 8
adenomas and 171 from 9 genes in 15 adenocarcinomas) were
disrupted by small indels for the 10 non-APC genes combined,
making the indel rate of APC in adenomas slightly higher (Tables 1
and 2). A bigger difference lies in the insertion/deletion ratio for
these indels: while an approximately equal number of codons was
disrupted by deletions and by insertions in both adenomas (47
versus 37) and adenocarcinomas (82 versus 89) for the other non-
APC genes, significantly more codons were disrupted by deletions
than by insertions for APC, 42 versus 18 for adenomas and 76
versus 19 for adenocarcinomas. This is consistent with the
frequently observed large deletions in APC exons described above.
Base substitutions in canine APC exons
When compared to the published canine genomic sequences
[1], a total of 800 base substitutions (249 for adenomas and 551 for
adenocarcinomas) were identified for APC exons, none of which
are among the published normal dog SNPs. In comparison, 2,127
such changes (740 for adenomas and 1,387 for adenocarcinomas)
were found for the 10 non-APC genes, with a substation rate
approximately the same as APC. In both APC and non-APC genes,
the base substitution rate is twice higher in adenocarcinomas than
in adenomas. However, as shown in Table 3, the G:CRA:T
transversion rate in APC is lower than that of the other genes
(especially for adenocarcinomas), consistent with the human
studies [42]. Below we will discuss how many codons are affected
by these bases substitutions by causing nonsense or missense
mutations.
APC Altered in Sporadic Canine Colorectal Tumors
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tions (11 for adenomas and 13 for adenocarcinomas) caused
nonsense (stop codons) mutations for 5 codons in 2 adenomas and
10 codons in 8 adenocarcinomas (Tables 1 and 2). For the non-
APC 10 genes, a total of 81 base substations (22 for adenomas and
59 for adenocarcinomas) resulted in 17 nonsense mutations for 6
genes in 6 adenomas and 51 nonsense mutations for 7 genes in 15
adenocarcinomas. Hence, nonsense mutations were slightly more
frequent in these non-APC genes in adenocarcinomas (Tables 1
and 2).
Missense mutation. We found that 708 substitutions (216
for adenomas and 492 for adenocarcinomas) resulted missense
mutations for 133 codons in 8 adenomas and 338 codons in 15
adenocarcinomas, some of which will undoubtedly be germline
and not cancer-related. For the other 10 genes, a total of 1,742
substitutions (612 for adenomas and 1,130 for adenocarcinomas)
resulted in missense mutations for 445 codons in 10 genes and 8
adenomas and 834 codons in 10 genes and 15 adenocarcinomas,
with a frequency approximately the same as that of APC (Tables 1
and 2).
Discussion
APC is the best-known human colorectal tumor suppressor gene,
with APC inactivation occurring in the vast majority of human
colorectal tumors and being the earliest event yet identified in
human sporadic colorectal tumorigenesis [16–33,42]. Similar to
their human counterparts, we report herein that APC is also
frequently altered in sporadic canine colorectal tumors and that its
alteration also appears to be an early event in canine colorectal
tumorigenesis. Specifically, we recurrently detected large deletions,
small indels, and an overall significantly higher mutation rate in
both adenomas and adenocarcinomas in APC coding exons, in
comparison with 10 other genes known to be altered in human
CRC or other human cancers.
The study also revealed other homologies in APC aberrations
between human and dog colorectal tumors. First, large deletions of
$10-bases long were very frequent in canine APC coding exons in
both adenomas and adenocarcinomas, at a rate of .18 times
higher than the other 10 genes (Tables 1 and 2). Single-base or
two-base deletions were also more common in canine APC, albeit
not as outstanding as large deletions. The base substitution rate, on
the other hand, was approximately the same between APC and
other genes examined. These observations are consistent with
many studies reporting recurrent allelic loss or loss of heterozy-
gosity (LOH) of APC in human colorectal tumors [16–33,42].
Second, in canine tumors, a substantial portion of the large
deletions clustered at codons 1143–1250, spanning the 15 aa
repeats region and downstream (Fig. 2). Similar to alterations
within the human APC MCR [30–32,42], these large deletions will
mostly likely disrupt the b-catenin-binding sites in the 15 aa
repeats region as well as in the 20 aa repeats region downstream
(Fig. 2). Indeed, altered b-catenin protein expression has been
noted in canine colorectal tumors [35,43]. Third, a significant
fraction of the small deletions was found within the armadillo
domain of APC in canine tumors (Fig. 2), consistent with a mouse
model study indicating that the armadillo domain can suppress
intestinal tumorigenesis [44]. Lastly, a lower frequency of
G:CRA:T mutations was observed for canine APC, similar to its
human counterpart [42], although a cleaner comparison for base
substitution would require the exclusion of germline mutations.
With only 23 canine colorectal tumors (8 adenomas and 15
adenocarcinomas) being sequenced and another 12 for qPCR
validation, we acknowledge that our sample size is small.
However, because of the high frequency of APC alterations,
particularly deletions, as shown in Tables 1 and 2, we believe that
Figure 2. Mutation distribution along canine APC codons in adenomas (top) and adenocarcinomas (middle). The x-axis indicates the
codon number of APC, and the y-axis indicates the total number of tumors altered at a specific codon for each category of missense mutations
(MisSense), nonsense mutations (nonSense), small indels, and large deletions. The data indicate that large deletions were frequent and clustered in
several regions of APC in both adenomas and adenocarcinomas (see the main text). Bottom: the image [modified based on reference 42] shows
domains (shared area) of APC, corresponding to the codon number indicated above, with the stars representing SAMP repeats of the axin binding
sites. The APC domains shown include the oligomerisation domain (codons 6–57), the armadillo region (codons 453–767), the 15 amino acid (aa)
repeats (codons 1020–1169), the 20 aa repeats (codons 1265–2035), the basic domain (codons 2200–2400), the EBI binding site (codons 2559–2771),
and the human disc large (HDLG) binding site (codons 2772–2843).
doi:10.1371/journal.pone.0050813.g002
Table 2. Mutated codons of APC and other 10 genes in canine colorectal tumors.*
Adenomas









APC 14,905 951 736 60 5 133
10 other genes 31,000 734 83 84 17 445
APC/others ratio 2.69 18.44 1.49 0.61 0.62
Adenocarcinomas









APC 31,972 2,185 1,698 95 10 338
10 other genes 58,721 1,371 124 171 51 834
APC/others ratio 2.93 25.15 1.02 0.36 0.74
*See Files S3 & S4 for detailed information for each gene.
doi:10.1371/journal.pone.0050813.t002
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above.
This work, along with our previous genome-wide copy number
abnormality study [15], provides critical evidence supporting that
sporadic canine tumors are likely to share similar molecular
pathogenesis pathways as their human counterparts. Hence, these
studies lay the crucial molecular foundation justifying the use of
sporadic canine CRCs in basic and clinical research to understand
and treat human CRCs.
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